临床试验

Fareon Open Label Device Clinical Trial

NCT：NCT07600320 · NOT_YET_RECRUITING

NCT编号NCT07600320

状态NOT_YET_RECRUITING

开始日期2026-05-01

完成时间2027-04-30

SponsorIcahn School of Medicine at Mount Sinai (OTHER)

First posted2026-05-20

Last updated2026-05-20

简要摘要

The purpose of this study is to assess the safety and feasibility of an at-home MMT treatment in patients with cognitive dysfunction related to acquired brain injury, Long COVID, traumatic brain injury, myalgic encephalomyelitis (ME/CFS), and other neurodegenerative diagnoses including but not limited to Alzheimer's disease and to collect data on safety and efficacy to inform the design of larger clinical studies.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。